Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
NTRK2
REST API REST API
Homo sapiens
NTRK2 is differentially expressed in 296 experiments: 217 organism parts: liver, cerebellum, ... (215 more);, 204 disease states: normal, glioblastoma, ... (202 more);, 81 cell types 295 cell lines 34 compound treatments and 80 other conditions.
Synonyms TRKB
Orthologs Q0VCN4_BOVIN (Bos taurus)   Ntrk2 (Rattus norvegicus)   F1P2E2_CHICK (Gallus gallus)   ntrk2a (Danio rerio)   ntrk2b (Danio rerio)   Ntrk2 (Mus musculus)   sev (Drosophila melanogaster)   ENSXETG00000004874 (Xenopus laevis)   ntrk2 (Xenopus laevis)   Q6JDI7_CANFA (Canis familiaris)   ENSCAFG00000001380 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, plasma membrane, protein binding, axon, membrane, Golgi membrane, regulation of dendrite development, protein tyrosine kinase activity, transmembrane receptor protein tyrosine kinase signaling pathway, cell differentiation, terminal button, ATP binding, multicellular organismal development, integral to plasma membrane, feeding behavior, postsynaptic density, regulation of metabolic process, axon terminus, dendrite, dendritic spine, growth cone, receptor activity, nucleotide binding, kinase activity, protein serine/threonine kinase activity, transmembrane receptor protein tyrosine kinase activity, nervous system development, glutamate secretion, cell surface, presynaptic active zone, protein kinase activity, activation of adenylate cyclase activity, regulation of neurotransmitter secretion, neuronal cell body, neurotrophin binding, brain-derived neurotrophic factor receptor signaling pathway, mechanoreceptor differentiation, vasculogenesis, brain-derived neurotrophic factor binding, excitatory synapse, neurotrophin receptor activity, positive regulation of synaptic transmission, glutamatergic, nerve growth factor receptor signaling pathway, retinal rod cell development, protein autophosphorylation, protein phosphorylation
InterPro Term Cys-rich_flank_reg_C, Ig_sub, LRR-contain_N, Prot_kinase_cat_dom, Ig-like, Ig_sub2, Ig_I-set, Tyr_kin_neurotrophic_rcpt_2, Tyr_kinase_NGF_rcpt, Ser/Thr_kinase_dom, Tyr_kinase_cat_dom, Ser-Thr/Tyr_kinase, Se/Thr_kinase-like_dom
UniProt Accession Q8WXJ7, Q8WXJ8, Q8WXJ4, Q8WXJ5, Q548C2, Q16620, B4DFV9, Q5VWE5
Gene-Disease Assocation OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY
Search EB-eye ENSG00000148053
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-6573, E-GEOD-7540, E-GEOD-3526, ... (36 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-2450, E-MTAB-62, ... (28 experiments)

Factor Value U/D Experiments
SW480
3
E-GEOD-18005, E-MEXP-1014, E-MTAB-37
MCF-7
1
3
E-GEOD-5823, E-GEOD-3529, E-GEOD-20081, E-GEOD-19639
HCC38
2
E-MTAB-62, E-MTAB-37
T84
2
E-GEOD-1474, E-MTAB-37
ew24 cell line, lentivirus treated
1
E-MTAB-62
COLO201
1
E-MTAB-37
289 more value(s).


Cell type

studied in E-GEOD-20193, E-MEXP-2426, E-GEOD-21668, E-GEOD-3920, E-GEOD-4219, ... (38 experiments)

Factor Value U/D Experiments
stromal cell
3
E-GEOD-3998, E-GEOD-10797, E-MEXP-2034
CD8+ T cell
2
E-GEOD-6740, E-MTAB-25
1
2
E-TABM-145, E-TABM-130
germ cell
1
E-MTAB-25
monocyte
1
E-MEXP-583
iPS cells from episomal vectors (Defined Factor sub-clone)
1
E-GEOD-20033
75 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-TABM-15, E-MEXP-2280, ... (69 experiments)

Factor Value U/D Experiments
lung adenocarcinoma
4
E-MTAB-37, E-GEOD-2514, E-MTAB-62, E-MEXP-231
ischemic cardiomyopathy
2
E-GEOD-1145, E-GEOD-1869
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
gastric carcinoma
2
E-GEOD-15460, E-MTAB-37
benign prostatic hyperplasia
2
E-MEXP-2034, E-GEOD-7307
Emery-Dreifuss muscular dystrophy
2
E-GEOD-3307, E-MTAB-62
198 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-5258, E-GEOD-6907, E-GEOD-5741, E-GEOD-697, ... (20 experiments)

Factor Value U/D Experiments
2,3-dimethoxy-1,4-naphthoquinone
1
E-GEOD-6907
no estradiol
1
E-GEOD-20081
unknown
1
E-GEOD-7307
hydrogen peroxide
1
E-GEOD-5339
ethanol
1
E-GEOD-3113
ponasterone A
1
E-GEOD-3113
28 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
1
E-GEOD-19519
thapsigargin
1
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-MTAB-37, E-GEOD-14359, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (11 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-MEXP-1251, ... (12 experiments)

Clinical treatment
studied in E-GEOD-2171, E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-GEOD-3140, E-MEXP-2359, E-GEOD-6236, ... (9 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-1323, E-GEOD-19743, E-GEOD-22544, E-GEOD-3325, E-TABM-147, ... (7 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Epiregulin elisa conc ng ml
studied in E-GEOD-5851

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-21589, E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, ... (7 experiments)

Genotype
studied in E-GEOD-3494, E-GEOD-2466, E-GEOD-17476, E-MEXP-421, E-GEOD-22593, ... (6 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-13073, E-GEOD-20540, E-GEOD-20504, E-MEXP-1446, ... (8 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-20559, E-TABM-276, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

Individual
studied in E-TABM-325, E-GEOD-974, E-MEXP-1956, E-GEOD-1926, E-MEXP-1648, ... (34 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-MEXP-561, E-GEOD-17400 ... (5 experiments)

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-MEXP-958, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

Organism
studied in E-GEOD-1801, E-AFMX-1, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-GEOD-2004, E-LGCL-5

Phenotype
studied in E-GEOD-1309, E-GEOD-21750, E-GEOD-6434, E-GEOD-1657, E-GEOD-17636 ... (5 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (6 experiments)

Qpcr egfr dct
studied in E-GEOD-5851

Qrt pcr areg dct
studied in E-GEOD-5851

Qrt pcr ereg dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10797, E-GEOD-18791

RNAi
studied in E-GEOD-12438, E-MEXP-101, E-MEXP-548, E-GEOD-3697, E-MEXP-1857 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-2466, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Strain or line
studied in E-TABM-125

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-19136, E-GEOD-19815, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments 98 240
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-GEOD-3494, E-GEOD-1561, E-GEOD-4922 ... (5 experiments)

Processing time: 0.272 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM